HIGHLANDS RANCH, Colo. - Officials from Sandhill Scientific have announced Food and Drug Administration (FDA) approval to market two new modalities for the diagnosis of gastrointestinal disorders.
The MultiChannel Intraluminal Impedance technology was designed to allow characterization of bolus movement within the esophagus. The technology is to be paired with traditional pressure manometry as part of a new device and diagnostic test referred to as esophageal function testing (EFT). It will also be used with a traditional pH ambulatory device that determines reflux episodes.
For additional information, log on to: www.sandhillsci.com.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.